EE53 A Cost of Illness Analysis of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) With FLT3 Mutations in Chile: A Public Payer Perspective
- Resource Type
- Abstract
- Source
- In
Value in Health June 2024 27(6) Supplement:S66-S67 - Subject
- Language
- ISSN
- 1098-3015